BioSpace News Archive

Drug Development

Fast Track Designation in Hand, Graphite Bio Guns for Definitive Sickle Cell Cure

GPH101 is an investigational next-generation gene-edited autologous hematopoietic stem cell (HSC) therapy.

May 3, 2022
·
2 min read
·
Hannah Chudleigh
Drug Development

Horizon Rheumatoid Arthritis Trial Advances Following Successful Phase II Study

Horizon Therapeutics announced its Phase II dazodalibep (HZN-4920) clinical trial has met its primary endpoint. Dazodalibep is a treatment for patients with Rheumatoid Arthritis (RA).

May 3, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Policy

Embattled Researcher Sabatini Withdraws from Consideration for NYU Position

David Sabatini has withdrawn his name for consideration for a faculty post at New York University Langone Health.

May 3, 2022
·
2 min read
·
Alex Keown
Business

Life Sciences Industry has Eyes on Texas’ Innovation Corridor

Over the past several years, The Lone Star State has been growing in significance as a life sciences hub. Now the industry is flocking to Hays County and its Innovation Corridor.

May 3, 2022
·
4 min read
·
Alex Keown
Business

At ISCT This Week, Cell & Gene Therapy Grows Up

BioSpace sat down with Sven Kili, 2022 ISCT Annual Meeting co-chair, to preview the event, which will focus on 4 key subject areas including launch and commercialization of cell and gene therapies.

May 3, 2022
·
5 min read
·
Heather McKenzie
Policy

FDA Officials call COVID-19 the ‘New Normal’ in Op-Ed

Three long-time FDA officials, Dr. Peter Marks, Dr. Janet Woodcock and Dr. Robert Califf wrote an op-ed in JAMA describing the reality that COVID-19 represents “the new normal.”

May 3, 2022
·
3 min read
·
Mark Terry
Inactivated Vaccines Market: Rise in Awareness among People about Immunization to Drive the Market

Albany NY, United States: A biological preparation that enhances or provides acquired immunity to a certain disease is known as vaccine.

May 3, 2022
·
5 min read
Hairy Cell Leukemia Treatment Market: Increase the number of hairy cell leukemia treatment patients to drive the market

Albany NY, United States: Hairy cell leukemia is an uncommon, chronic, slow-growing malignancy caused due to excessive production of B cells by the bone marrow.

May 3, 2022
·
5 min read
Global Cosmetic Dentistry Market Growth Analysis – Forecast [2020-2030]

The inclination towards improving the beauty and aesthetics of an individual has emerged as a lifestyle and is getting widely adopted worldwide.

May 3, 2022
·
5 min read
Competent Cells Market: Rise in government investment in research activities to drive the market

Albany NY, United States: E. coli have the property to incorporate foreign DNA into it, and hence are termed as competent cells.

May 3, 2022
·
5 min read